|
|
|
The 14th Annual Meeting of the Association of Biomolecular Resource Facilities (ABRF), Sacramento, California
20 March 2010 - 23 March 2010
ABRF 2010 – March 20-23, 2010 – Sacramento, California
The 14th Annual Meeting of the Association of Biomolecular Resource Facilities (ABRF) “Translating Basic Research with Advances in Biomolecular Technology” will feature engaging plenary speakers, world-class scientific lectures, social networking events, poster sessions and a not-to-be-missed exhibition showcasing the latest technologies.
|
CNPN Symposium - Montreal, Canada
09 May 2010 - 10 May 2010
CNPN Symposium provides an open forum for scientists to present and discuss new developments in proteomic research. Features include a world-class program of invited speakers from industry and academia, poster presentations and exhibitor showcases.
|
Advances in Antibody and Peptide Therapeutics, 8-9 June 2010, Berlin, Germany
08 June 2010 - 09 June 2010
This conference will be following on from the successful Peptides Europe conferences. It will cover topics looking into the utilisation of peptides and antibodies in therapies for an array of diseases, which, in terms of patient treatment, promises to be huge in the future. Our conference will give delegates the latest on the techniques being used.
|
|
|
|
|
|
Compound Management Technologist, St Jude Children's Research Hospital, Memphis, TN
St. Jude Children's Research Hospital, located in Memphis, Tennessee, is a premier center for research and treatment of potentially fatal childhood diseases, including cancer and certain blood, genetic, and immunodeficiency disorders. The hospital's mission is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. St. Jude is dedicated to providing unsurpassed patient care and to advancing the health of children through biomedical research.
|
|
|
Postdoctoral Research Associate
Northeastern University
The Center for Drug Discovery at Northeastern University is dedicated to designing and discovering novel medications, developing technologies, and training scientists in the multidisciplinary field of drug discovery. We are recruiting a Postdoctoral Research Associate with expertise in protein-based mass spectrometry and /or proteomics.
|
|
|
Product Manager - Techne, Stone, Staffordshire
Bibby Scientific
Bibby Scientific Ltd is one of the world’s leading manufacturers of Laboratory bench-top scientific equipment. For more information about the company, please visit their website (www.bibby-scientific.com).
|
|
|
Assistant/Associate Professors
Chinese University of Hong Kong
The newly established School of Biomedical Sciences, Stem Cell and Regeneration theme is actively looking for stem cell biologist over the next 2 years.
|
|
|
Macromolecular X-ray Crystallgrapher
Xtal Biostructures
Ph.D. Protein Crystallographer: We seek an experienced crystallographer with post-doctoral experience to participate in a number of our diverse structural biology activities.
|
|
|
Marketing Communications Specialist Position in San Jose, CA
Thermo Fisher Scientific
This position, based in San Jose, CA within the SID Division, will manage promotion of Thermo Scientific mass spectrometry products and services.
|
|
|
|
A simple, fast and quantitative single-step dead-cell indicator for flow cytometry
life technologies
We have evaluated a series of new compounds for dead cell stain and identified a new product, SYTOX® AADvancedTM dead cell stain, which demonstrates improved properties over 7-AAD. These properties make the SYTOX® AADvancedTM dead cell stain a simple, fast and quantitative single-step no-wash dead-cell indicator as well as ideal for use in multicolor application requiring DNA content.
|
Protein array-based screening of autoantibody signatures
Fondazione Istituto Nazionale Genetica Molecolare
The evidence for an association between autoimmune diseases and chronic HCV infection has been clearly established. To this aim, a protein array was employed to analyze serum samples of HCV patients w/wo autoimmune complications, of patients with autoimmune hepatitis but not infected with HCV and of healthy donors as controls. A panel of autoantigens able to discriminate among the three groups of patients was identified for potential use as biomarkers.
|
|
| |
|
|
|
|
Multiplexed Diagnostics 2009 Market Report
Published March 2009
Multiplexed diagnostics are the long-awaited ascendance of ’omics into healthcare. The promise of multiple measurements to characterize complexity is finally being realized.
|
Cancer Personalized Medicine 2008
Published July 2008
The Cancer Personalized Medicine marketplace represents the paradigm for personalized medicine market evolution and Select Biosciences focuses in this report on the various commercialized cancer predictor tests, their current status, traction in the marketplace, quantitative market opportunities, and the factors that are driving as well as challenging the expansion of this space. Personalized Medicine, especially as it relates to Cancer, is undergoing significant growth and this report focuses i
|
|
|